Thyroid-stimulating hormone is associated with trabecular bone score and 5-year incident fracture risk in euthyroid postmenopausal women: the OsteoLaus cohort.

Détails

Ressource 1Télécharger: Vendrami2021_Article_Thyroid-stimulatingHormoneIsAs.pdf (744.73 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC 4.0
ID Serval
serval:BIB_2110BB700E84
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Thyroid-stimulating hormone is associated with trabecular bone score and 5-year incident fracture risk in euthyroid postmenopausal women: the OsteoLaus cohort.
Périodique
Osteoporosis international
Auteur⸱e⸱s
Vendrami C., Marques-Vidal P., Gonzalez Rodriguez E., Hans D., Waeber G., Lamy O.
ISSN
1433-2965 (Electronic)
ISSN-L
0937-941X
Statut éditorial
Publié
Date de publication
01/2022
Peer-reviewed
Oui
Volume
33
Numéro
1
Pages
195-204
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
Thyroid-stimulating hormone (TSH) excess or deficiency influences bone density and fracture risk. Nevertheless, does TSH in the reference range influence bone health? In euthyroid postmenopausal women, TSH levels in the reference range were positively associated with trabecular bone score and negatively with incident fractures, without affecting BMD.
Subclinical hyperthyroidism is associated with low bone mineral density (BMD) and increased fracture risk. In healthy postmenopausal women, association between thyroid-stimulating hormone (TSH) in the normal range and BMD is contradictory. Trabecular bone score (TBS), an index of bone micro-architecture, is often decreased in secondary osteoporosis (OP). The aim was to determine the association between thyroid hormones (TSH, fT4) and BMD, TBS, and the incident 5-year OP fractures, in euthyroid post-menopausal women.
We assessed 1475 women of the CoLaus/OsteoLaus cohort. We evaluated BMD at lumbar spine, femoral neck and total hip, lumbar spine TBS, and vertebral fracture with DXA. Incident major OP fractures were evaluated 5 years later by questionnaire and DXA. Women with anti-osteoporotic, antidiabetic, thyroid-modifying, hormone replacement, or systemic corticoid treatment were excluded.
Five hundred thirty-three women (age 68.4 ± 7.3 years, BMI 25.9 ± 4.6 kg/m <sup>2</sup> , TSH 2.03 ± 0.87 mU/l, fT4 15.51 ± 1.85 pmol/l) met the inclusion criteria. There was no significant association between TSH or fT4 and BMD measures at any site. A positive association was found between TSH and TBS (β = 0.138, p < 0.01), even after adjusting for age, BMI, and duration of menopause (β = 0.086, p < 0.05). After a 5-year follow-up, women with incident major OP fractures had lower TSH levels (1.77 ± 0.13 vs. 2.05 ± 0.04 mU/l, p < 0.05) than women without fractures, while no difference was found for fT4.
In euthyroid postmenopausal women, TSH levels were positively associated with TBS and negatively with incident fractures, without affecting BMD. Further studies are needed to evaluate the influence of thyroid hormones on TBS.
Mots-clé
Absorptiometry, Photon, Aged, Bone Density, Cancellous Bone/diagnostic imaging, Female, Humans, Lumbar Vertebrae/diagnostic imaging, Middle Aged, Osteoporotic Fractures/epidemiology, Osteoporotic Fractures/etiology, Postmenopause, Thyrotropin, Bone mineral density, Fractures, Osteoporosis, Thyroid hormones, Trabecular bone score
Pubmed
Web of science
Open Access
Oui
Création de la notice
10/09/2021 17:25
Dernière modification de la notice
20/07/2022 6:08
Données d'usage